Ligand Pharmaceuticals Inc (NASDAQ:LGND)

78.45
Delayed Data
As of May 06
 +0.78 / +1.00%
Today’s Change
41.99
Today|||52-Week Range
90.48
+47.43%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 92.00, with a high estimate of 116.00 and a low estimate of 82.00. The median estimate represents a +17.27% increase from the last price of 78.45.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.27
Sales
$13.5M
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -55.00%
 
 
 
 
 
 
Growthannually 38.82%
 
 
 
 
 
 

Sales

Growthquarterly -41.13%
 
 
 
 
 
 
Growthannually 27.50%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account